Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News The Spectranetics Corporation SPNC

Healthcare Medical Devices
"The Spectranetics Corp manufactures and sells single-use medical devices which are used to cross, prepare, and treat arterial blockages in the legs and heart and to remove pacemaker and defibrillator cardiac leads."

Recent & Breaking News (NDAQ:SPNC)

Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien

GlobeNewswire January 27, 2015

Spectranetics to Present at the J.P. Morgan 33rd Annual Healthcare Conference

GlobeNewswire December 29, 2014

2014 Proves a Successful Year for Major Bioscience Fundings, Including Key Merger and Acquisition Activity in Colorado

Business Wire December 22, 2014

Spectranetics Outlines Growth Opportunities at Analyst & Investor Meeting

GlobeNewswire December 4, 2014

Spectranetics to Host Investor & Analyst Meeting

GlobeNewswire November 17, 2014

Spectranetics to Participate in Upcoming Investor Conferences

GlobeNewswire November 5, 2014

Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien

GlobeNewswire November 2, 2014

Spectranetics Achieves Third Quarter 2014 Revenue of $58.8 Million

GlobeNewswire October 23, 2014

Spectranetics to Hold 2014 Third Quarter Financial Results Conference Call on October 23

GlobeNewswire October 9, 2014

EXCITE ISR Proves Superiority in Safety, Efficacy of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at TCT 2014

GlobeNewswire September 16, 2014

Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C.

GlobeNewswire September 10, 2014

Spectranetics to Participate in Upcoming Investor Conferences

GlobeNewswire August 20, 2014

Spectranetics to Present at the Canaccord Genuity 34th Annual Growth Conference

GlobeNewswire July 30, 2014

Spectranetics Achieves Second Quarter 2014 Revenue of $43.6 Million

GlobeNewswire July 24, 2014

Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis

GlobeNewswire July 23, 2014

AngioScore Launches New 200 mm Length AngioSculpt(R) Scoring Balloon Catheters

GlobeNewswire July 9, 2014

Spectranetics to Hold 2014 Second Quarter Financial Results Conference Call on July 24

GlobeNewswire July 7, 2014

Spectranetics Completes Acquisition of AngioScore Inc.

GlobeNewswire June 30, 2014

EXCITE Clinical Trial Data Reported at NCVH Demonstrates Acute, Superior Procedural Success

GlobeNewswire June 4, 2014

Spectranetics Announces Closing of $230 Million Convertible Senior Notes Offering

GlobeNewswire June 3, 2014